Description
Retatrutide is a synthetic peptide compound that has been investigated in research settings for its activity across multiple metabolic signaling pathways. It is characterized as a multi-receptor agonist, interacting with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypein (GIP), and glucagon receptors (GCGR) in preclinical and clinical research environments.
Due to its broad receptor profile, Retatrutide has become a subject of scientific interest in studies examining metabolic regulation, energy balance, and endocrine signaling mechanisms. Research focuses on understanding how simultaneous receptor engagement may influence complex physiological pathways
Disclaimer:
This product is intended for research purposes only. Not for human or animal consumption. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Reviews
There are no reviews yet.